418 related articles for article (PubMed ID: 33391538)
1. Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy.
Chen J; Ding ZY; Li S; Liu S; Xiao C; Li Z; Zhang BX; Chen XP; Yang X
Theranostics; 2021; 11(3):1345-1363. PubMed ID: 33391538
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
3. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
[TBL] [Abstract][Full Text] [Related]
4. Targeting TGFβ signal transduction for cancer therapy.
Liu S; Ren J; Ten Dijke P
Signal Transduct Target Ther; 2021 Jan; 6(1):8. PubMed ID: 33414388
[TBL] [Abstract][Full Text] [Related]
5. A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers.
Zhu H; Gu X; Xia L; Zhou Y; Bouamar H; Yang J; Ding X; Zwieb C; Zhang J; Hinck AP; Sun LZ; Zhu X
Clin Cancer Res; 2018 Jun; 24(12):2780-2793. PubMed ID: 29549162
[No Abstract] [Full Text] [Related]
6. TGFβ Signaling in the Tumor Microenvironment.
Goulet CR; Pouliot F
Adv Exp Med Biol; 2021; 1270():89-105. PubMed ID: 33123995
[TBL] [Abstract][Full Text] [Related]
7. Targeting the TGFβ pathway for cancer therapy.
Neuzillet C; Tijeras-Raballand A; Cohen R; Cros J; Faivre S; Raymond E; de Gramont A
Pharmacol Ther; 2015 Mar; 147():22-31. PubMed ID: 25444759
[TBL] [Abstract][Full Text] [Related]
8. PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer.
Agajanian M; Campeau A; Hoover M; Hou A; Brambilla D; Kim SL; Klemke RL; Kelber JA
PLoS One; 2015; 10(8):e0135748. PubMed ID: 26267863
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of TGFβ signaling and its implications in anticancer treatments.
Calone I; Souchelnytskyi S
Exp Oncol; 2012; 34(1):9-16. PubMed ID: 22453142
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix as a contextual determinant of transforming growth factor-β signaling in epithelial-mesenchymal transition and in cancer.
Cichon MA; Radisky DC
Cell Adh Migr; 2014; 8(6):588-94. PubMed ID: 25482625
[TBL] [Abstract][Full Text] [Related]
11. The involvement of lipid raft pathway in suppression of TGFβ-mediated metastasis by tolfenamic acid in hepatocellular carcinoma cells.
Sun J; Tao R; Mao T; Feng Z; Guo Q; Zhang X
Toxicol Appl Pharmacol; 2019 Oct; 380():114696. PubMed ID: 31381904
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta signaling in cancer treatment.
Fabregat I; Fernando J; Mainez J; Sancho P
Curr Pharm Des; 2014; 20(17):2934-47. PubMed ID: 23944366
[TBL] [Abstract][Full Text] [Related]
14. TGFβ and matrix-regulated epithelial to mesenchymal transition.
Moustakas A; Heldin P
Biochim Biophys Acta; 2014 Aug; 1840(8):2621-34. PubMed ID: 24561266
[TBL] [Abstract][Full Text] [Related]
15. Difference of TGF-β/Smads signaling pathway in epithelial-mesenchymal transition of normal colonic epithelial cells induced by tumor-associated fibroblasts and colon cancer cells.
Wang XL; Huang C
Mol Biol Rep; 2019 Jun; 46(3):2749-2759. PubMed ID: 30835040
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β: A therapeutic target for cancer.
Haque S; Morris JC
Hum Vaccin Immunother; 2017 Aug; 13(8):1741-1750. PubMed ID: 28575585
[TBL] [Abstract][Full Text] [Related]
17. Notch prevents transforming growth factor-beta-assisted epithelial-mesenchymal transition in cultured limbal progenitor cells through the induction of Smad7.
Tsai TH; Sun MH; Ho TC; Ma HI; Liu MY; Tsao YP
Mol Vis; 2014; 20():522-34. PubMed ID: 24791137
[TBL] [Abstract][Full Text] [Related]
18. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
19. Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells.
Jeon MJ; Kim WG; Lim S; Choi HJ; Sim S; Kim TY; Shong YK; Kim WB
Mol Cell Endocrinol; 2016 Jan; 419():113-23. PubMed ID: 26463583
[TBL] [Abstract][Full Text] [Related]
20. All-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells: ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGFβ).
Zanetti A; Affatato R; Centritto F; Fratelli M; Kurosaki M; Barzago MM; Bolis M; Terao M; Garattini E; Paroni G
J Biol Chem; 2015 Jul; 290(29):17690-17709. PubMed ID: 26018078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]